Anastomotic Airway Complications After Lung Transplantation
NCT ID: NCT02265835
Last Updated: 2014-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
432 participants
OBSERVATIONAL
2014-01-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Disordered Breathing and Lung Transplantation
NCT01179087
Sleep-disordered Breathing After Solid Organ Transplantation
NCT03142022
Incidence, Risk Factors and Outcomes of Diaphragm Dysfunction After Lung Transplantation
NCT04103996
Determinants of Immunosuppressive Dose Requirements in Children After Solid Organ Transplantation
NCT01767350
Short- and Long-Term Renal Outcomes Following Lung Transplantation
NCT03046277
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cases of anastomotic airway complication
Cases of anastomotic airway complication
no intervention
no intervention
Patients with normal anastomotic healing
Patients with normal anastomotic healing
no intervention
no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yserbyt Jonas
MD
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML6736
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.